Abonnement à la biblothèque: Guest
Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections
Critical Reviews™ in Immunology
Facteur d'impact: 1.352 Facteur d'impact sur 5 ans: 3.347 SJR: 0.657 SNIP: 0.55 CiteScore™: 2.19

ISSN Imprimer: 1040-8401
ISSN En ligne: 2162-6472

Volumes:
Volume 39, 2019 Volume 38, 2018 Volume 37, 2017 Volume 36, 2016 Volume 35, 2015 Volume 34, 2014 Volume 33, 2013 Volume 32, 2012 Volume 31, 2011 Volume 30, 2010 Volume 29, 2009 Volume 28, 2008 Volume 27, 2007 Volume 26, 2006 Volume 25, 2005 Volume 24, 2004 Volume 23, 2003 Volume 22, 2002 Volume 21, 2001 Volume 20, 2000 Volume 19, 1999 Volume 18, 1998 Volume 17, 1997 Volume 16, 1996 Volume 15, 1995 Volume 14, 1994

Critical Reviews™ in Immunology

DOI: 10.1615/CritRevImmunol.2014010183
pages 91-102

Tumor Plasticity Interferes with Anti-Tumor Immunity

Salem Chouaib
Thumbay Research Institute for Precision Medicine, Gulf Medical University, Ajman 4184, United Arab Emirates; INSERM UMR 1186, Integrative Tumor Immunology and Genetic Oncology, Gustave Roussy, EPHE, Faculty de Médecine University Paris-Sud, University Paris-Saclay, Villejuif F-94805, France
Bassam Janji
Laboratory of Experimental Hemato-Oncology, Department of Oncology, Public Research Center for Health (CRP-Sante), L-1526 Luxembourg City, Luxembourg
Andres Tittarelli
Institut National de la Sante et de la Recherche Medicale (INSERM U753); Institut Federatif de Recherche 54 (IFR54); Institut de cancerologie Gustave Roussy. F-94800 Villejuif, France
Alexander Eggermont
Institut National de la Sante et de la Recherche Medicale (INSERM U753); Institut Federatif de Recherche 54 (IFR54); Institut de cancerologie Gustave Roussy. F-94800 Villejuif, France
Jean Paul Thiery
Cancer Science Institute of Singapore, National University of Singapore; Institute of Molecular and Cell Biology, A*STAR, Singapore; Department of Biochemistry, National University of Singapore, Singapore

RÉSUMÉ

Since tumor cell plasticity was first shown to be crucial in tumor promotion and immune surveillance evasion, it has become an issue of intense investigation. Several mechanisms are associated with the acquisition of tumor cell plasticity and immune evasion, including loss of epithelial phenotype through epithelial-to-mesenchymal transition (EMT). We discuss recent evidence revealing that tumor cell plasticity may lead to the emergence of immunoresistant variants and how the tumor microenvironment evolves to shape this plasticity. We argue that targeting carcinoma cell plasticity represents a novel strategy to better control the emergence of resistant variants and to ensure more effective cancer therapies. In this context, the design of innovative integrative immunotherapy approaches is warranted.


Articles with similar content:

Molecular Mechanisms Underlying the Role of MicroRNAs in Resistance to Epidermal Growth Factor Receptor-Targeted Agents and Novel Therapeutic Strategies for Treatment of Non-Small-Cell Lung Cancer
Critical Reviews™ in Oncogenesis, Vol.18, 2013, issue 4
Elena Galvani, Godefridus J. Peters, Mina Maftouh, Elisa Giovannetti, Amir Avan
Microenvironmental Hypoxia Orchestrating the Cell Stroma Cross Talk, Tumor Progression and Antitumor Response
Critical Reviews™ in Immunology, Vol.31, 2011, issue 5
Muhammad Zaeem Noman, Yosra Messai, Thibault Carre, Salem Chouaib, Bassam Janji, Meriem Hasmim, Intissar Akalay, Marine Meron
ANP-NPRA Signaling Pathway−A Potential Therapeutic Target for the Treatment of Malignancy
Critical Reviews™ in Eukaryotic Gene Expression, Vol.23, 2013, issue 2
Jia Zhang, Jiansheng Wang, Ya Yang, Kai Sun, Zhilong Zhao, Min Li
Yin Yang 1 Is a Tumor Immune-Suppressor Gene Product
Forum on Immunopathological Diseases and Therapeutics, Vol.1, 2010, issue 1-2
Stavroula Baritaki
Histone Deacetylases and Cancer-Associated Angiogenesis: Current Understanding of the Biology and Clinical Perspectives
Critical Reviews™ in Oncogenesis, Vol.20, 2015, issue 1-2
Vincent Castronovo, Andrei Turtoi, Paul Peixoto, Akeila Bellahcene